Skip to content
Resources > Reports

AlphaCut: Forecasting IPO and Deal Momentum Beyond 2025

By Barbara Tague, Financial Research Leader
IndustryFinancial Services

Recent findings from the AlphaSense platform indicate that H1 2025 marked the strongest H1 since 2021 for the U.S. IPO market.

In this report, we surface trending insights and perspectives within analyst research reports, key expert transcripts, and industry publications.

AlphaCut is your trusted source for the trends and intelligence making the most waves in today’s market. Download the report today to streamline and simplify your deal workflow.

About the Author

  • Barbara Tague, Financial Research Leader

    Barb is a Financial Research Leader covering the financial services segment at AlphaSense. Previously, she spent more than a decade at institutional investment managers and at a SaaS startup leading business development, content, and product initiatives.

Explore more

All articles

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
ReportAIFinancial ServicesTech, Media, & Telecom
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Report
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
ReportLife Sciences & Healthcare
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.